The Oncosearch | Oncotarget

An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid Research Paper

Laura Moracci, Francesca Sensi, Andrea Biccari, Sara Crotti, Elisa Gaio, Federico Benetti, Pietro Traldi, Salvatore Pucciarelli, Marco Agostini

Published Feb 22, 2022 · Vol. 13, No. 1 · pp. 476-489

Keywords: HT29, 5-fluorouracil, epigallocatechin-3-gallate, molecular complexes, gastrointestinal model

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer Correction

Bing Guan, Kaijie Wu, Jin Zeng, Shan Xu, Lijun Mu, Yang Gao, Ke Wang, Zhenkun Ma, Juanhua Tian, Qi Shi, Peng Guo, Xinyang Wang, Dalin He, Yuefeng Du

Published Feb 22, 2022 · Vol. 13, No. 1 · pp. 507-507

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma Research Paper

Nancy Y. Villa, Masmudur M. Rahman, Joseph Mamola, Meaghen E. Sharik, Ana Lemos de Matos, Jacquelyn Kilbourne, Kenneth Lowe, Juliane Daggett-Vondras, Julia D'Isabella, Elizabeth Goras, Marta Chesi, P. Leif Bergsagel, Grant McFadden

Published Feb 21, 2022 · Vol. 13, No. 1 · pp. 490-504

Keywords: myxoma virus, multiple myeloma, combination therapy, autologous transplantation, oncolytic virus

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter? Research Paper

Somayeh Khazaei, Linn Nilsson, Gabriel Adrian, Helga Tryggvadottir, Elise Konradsson, Signe Borgquist, Karolin Isaksson, Crister Ceberg, Helena Jernström

Published Feb 17, 2022 · Vol. 13, No. 1 · pp. 439-453

Keywords: human breast cancer, radiation therapy, vitamin C, in vitro, clinical outcome

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo Research Paper

Mark H. Murdock, George S. Hussey, Jordan T. Chang, Ryan C. Hill, David G. Nascari, Aparna V. Rao, Kirk C. Hansen, Lesley M. Foley, T. Kevin Hitchens, Nduka M. Amankulor, Stephen F. Badylak

Published Feb 16, 2022 · Vol. 13, No. 1 · pp. 426-438

Keywords: extracellular matrix, brain cancer, glioma treatment, dynamic reciprocity, tissue organization field theory

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

Alexander W. Pohlman, Hita Moudgalya, Lia Jordano, Gabriela C. Lobato, David Gerard, Michael J. Liptay, Christopher W. Seder, Jeffrey A. Borgia

Published Feb 15, 2022 · Vol. 13, No. 1 · pp. 393-407

Keywords: IGF, lung cancer, biomarkers, screening, prognostication

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells Correction

Guodong Xiao, Xiang Li, Gang Li, Boxiang Zhang, Chongwen Xu, Sida Qin, Ning Du, Jichang Wang, Shou-Ching Tang, Jing Zhang, Hong Ren, Ke Chen, Xin Sun

Published Feb 15, 2022 · Vol. 14, No. 1 · pp. 809-809

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model Research Paper

Karen Cravero, Morgan V. Pantone, Dong Ho Shin, Riley Bergman, Rory Cochran, David Chu, Daniel J. Zabransky, Swathi Karthikeyan, Ian G. Waters, Natasha Hunter, D. Marc Rosen, Kelly Kyker-Snowman, W. Brian Dalton, Berry Button, Dan Shinn, Hong Yuen Wong, Joshua Donaldson, Paula J. Hurley, Sarah Croessmann, Ben Ho Park

Published Feb 11, 2022 · Vol. 13, No. 1 · pp. 373-386

Keywords: NOTCH1, TNBC, breast cancer, PEST

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer Correction

Lokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, Charles Warden, Xueli Liu, David Horne, Sanjay Awasthi, Ravi Salgia, Sharad S. Singhal

Published Feb 11, 2022 · Vol. 13, No. 1 · pp. 331-331

Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker Research Paper

Vincenz Sahm, Carlo Maurer, Theresa Baumeister, Akanksha Anand, Julia Strangmann, Roland M. Schmid, Timothy C. Wang, Michael Quante

Published Feb 10, 2022 · Vol. 13, No. 1 · pp. 347-359

Keywords: Barrett's esophagus, telomere shortening, esophageal cancer, risk factor, TERT/TERC

A comparison of ⁶⁴Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α_νβ₆ Research Paper

Truc T. Huynh, Sreeja Sreekumar, Cedric Mpoy, Buck E. Rogers

Published Feb 10, 2022 · Vol. 13, No. 1 · pp. 360-372

Keywords: integrin α_νβ₆, PEGylation, Copper-64, DOTA, PCTA

Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity Research Paper

Daniel Menendez, Jay R. Anand, Carri C. Murphy, Whitney J. Bell, Jiaqi Fu, Nadia Slepushkina, Eugen Buehler, Scott E. Martin, Madhu Lal-Nag, John L. Nitiss, Michael A. Resnick

Published Feb 4, 2022 · Vol. 13, No. 1 · pp. 332-346

Keywords: tumor suppressor, siRNA screen, synthetic lethality, ICE assay, Top2 covalent complexes

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells Research Paper

Benigno C. Valdez, David Murray, Bin Yuan, Yago Nieto, Uday Popat, Borje S. Andersson

Published Feb 2, 2022 · Vol. 13, No. 1 · pp. 319-330

Keywords: ABT199/venetoclax, busulfan, cyclophosphamide, fludarabine, acute myeloid leukemia

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies Review

Ekaterina A. Lesovaya, Daria Chudakova, Gleb Baida, Ekaterina M. Zhidkova, Kirill I. Kirsanov, Marianna G. Yakubovskaya, Irina V. Budunova

Published Feb 1, 2022 · Vol. 13, No. 1 · pp. 408-424

Keywords: glucocorticoid receptor, glucocorticoids, SEGRAM, REDD1, drug repurposing

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

Samuel Z. Desind, Joseph R. Iacona, Christina Y. Yu, Antonina Mitrofanova, Carol S. Lutz

Published Jan 29, 2022 · Vol. 13, No. 1 · pp. 291-306

Keywords: PACER, COX-2, PGE₂, lung adenocarcinoma, inflammation

GZ17-6.02 and axitinib interact to kill renal carcinoma cells Research Paper

Laurence Booth, Cameron West, Robert P. Moore, Daniel Von Hoff, Paul Dent

Published Jan 28, 2022 · Vol. 13, No. 1 · pp. 281-290

Keywords: GZ17-6.02, axitinib, renal cell carcinoma, autophagy, HDAC

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, Massimo Cristofanilli

Published Jan 26, 2022 · Vol. 13, No. 1 · pp. 273-280

Keywords: ERBB2, HER2, next-generation sequencing, copy number gain, circulating tumor DNA

Correction: HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation Correction

Yue-Mei Xu, Hong-Jiang Wang, Fang Chen, Wan-Hua Guo, Yan-Yang Wang, Hang-Yu Li, Jin-Hai Tang, Ying Ding, Ya-Chen Shen, Min Li, Wen-Ying Xuan, Lin-Hui Liu, Jia Wang, Xue-Rong Wang, Ze-Jun Gao, Xiu-Bin Liang, Dong-Ming Su

Published Jan 25, 2022

Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer Research Paper

Kanako Sendo, Manabu Seino, Tsuyoshi Ohta, Satoru Nagase

Published Jan 24, 2022 · Vol. 13, No. 1 · pp. 224-236

Keywords: endometrial cancer, glutathione, sulfasalazine, xCT, cystathionine gamma-lyase

Correction: Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression Correction

Hsien-Ming Wu, Hong-Yuan Huang, Andrew V. Schally, Angel Chao, Hung-Hsueh Chou, Peter C.K. Leung, Hsin-Shih Wang

Published Jan 22, 2022

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid Research Paper

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer Correction

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma Research Paper

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter? Research Paper

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo Research Paper

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells Correction

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model Research Paper

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer Correction

Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker Research Paper

A comparison of ⁶⁴Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α_νβ₆ Research Paper

Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity Research Paper

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells Research Paper

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies Review

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

GZ17-6.02 and axitinib interact to kill renal carcinoma cells Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Correction: HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation Correction

Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer Research Paper

Correction: Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid Research Paper

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer Correction

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma Research Paper

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter? Research Paper

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo Research Paper

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells Correction

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model Research Paper

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer Correction

Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker Research Paper

A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6 Research Paper

Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity Research Paper

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells Research Paper

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies Review

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

GZ17-6.02 and axitinib interact to kill renal carcinoma cells Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Correction: HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation Correction

Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer Research Paper

Correction: Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression Correction

A comparison of ⁶⁴Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α_νβ₆ Research Paper